Bessemer Securities’s Teva Pharmaceuticals TEVA Stock Holding History

Bessemer Securities’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-30,048	Closed	-$1.7M	–	59
2015 Q3	$1.7M	Hold	30,048	–	–	0.65%	43
2015 Q2	$1.78M	Buy	+30,048	New	+$1.85M	0.62%	49

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bessemer Securities's TEVA Position: Q4 2015 in Review

Bessemer Securities sold out of Teva Pharmaceuticals (TEVA) in Q4 2015, closing a stake of 30,048 shares — an estimated $1.7M sold.

Bessemer Securities first reported a position in TEVA in Q2 2015 and held it in 2 quarters. The position peaked at $1.78M in Q2 2015. 876 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

Bessemer Securities reported no remaining Teva Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Bessemer Securities sold 30,048 Teva Pharmaceuticals shares in Q4 2015, an estimated $1.7M.
Bessemer Securities first reported a position in Teva Pharmaceuticals in Q2 2015 and held it in 2 quarters.
Bessemer Securities's Teva Pharmaceuticals position peaked at $1.78M in Q2 2015.
876 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2015.

Based on Bessemer Securities's 13F filing for Q4 2015, filed 12 Feb 2016.